dict.md logo
Results for F in English, page 33
FD-211
FD-4 protein, Xenopus
FD-4' protein, Xenopus
FD-501
FD-594, antibiotic
FD-838
FD-891
FD-892
FD-895
FD-duct
FD-ducts
Fd-GOGAT
FD&C Blue No. 1
FD&C Blue No. 2
FD&C BLUE NO. 2 40 MG INTRAMUSCULAR INJECTION, SOLUTION [INDIGO]
FD&C BLUE NO. 2 40 MG INTRAVENOUS INJECTION, SOLUTION [INDIGO]
FD&C BLUE NO. 2 8 MG INTRAMUSCULAR INJECTION [INDIGO]
FD&C BLUE NO. 2 8 MG INTRAMUSCULAR INJECTION, SOLUTION [INDIGO]
FD&C BLUE NO. 2 8 MG INTRAVENOUS INJECTION [INDIGO]
FD&C BLUE NO. 2 8 MG INTRAVENOUS INJECTION, SOLUTION [INDIGO]
FD&C Blue No. 2 8 MG/ML
FD&C Blue No. 2 8 MG/ML Injectable Solution
FD&C Blue No. 2 Injectable Solution
FD&C BLUE NO. 2--ALUMINUM LAKE 8 MG INTRAVENOUS INJECTION, SOLUTION [INDIGO]
FD&C BLUE NO. 2. 40 MG INTRAMUSCULAR INJECTION, SOLUTION [INDIGO]
FD&C BLUE NO. 2. 40 MG INTRAVENOUS INJECTION, SOLUTION [INDIGO]
FD&C BLUE NO. 2. 8 MG INTRAMUSCULAR INJECTION [INDIGO]
FD&C BLUE NO. 2. 8 MG INTRAMUSCULAR INJECTION, SOLUTION [INDIGO]
FD&C BLUE NO. 2. 8 MG INTRAVENOUS INJECTION [INDIGO]
FD&C BLUE NO. 2. 8 MG INTRAVENOUS INJECTION, SOLUTION [INDIGO]
FD&C blue No.1
FD&C GREEN NO. 3
FD&C Orange No. 2
FD&C RED NO. 2
FD&C RED NO. 3
FD&C RED NO. 3 3.2 GM DENTAL SOLUTION [VA]
FD&C RED NO. 3 3.2 GM ORAL SOLUTION [VA]
FD&C RED NO. 3 3.2 GM TOPICAL SOLUTION [VA]
FD&C RED NO. 40
FD&C violet no. 1
FD&C Yellow No. 1
FD&C Yellow No. 3
FD&C YELLOW NO. 5
FD&C YELLOW NO. 6
FD137 cpd
Fd17 protein, mouse
FD2 dendrimer
FD501
FD6 compound
FD7 compound
FD838 cpd
FDA
FDA 0084
FDA 0345
FDA Approval
FDA APPROVED NERVE STIMULATOR, WITH REPLACEABLE BATTERIES, FOR TREATMENT OF NAUSEA AND VOMITING
FDA CDRH Terminology
FDA Center For Devices and Radiological Health Terminology
FDA class III device
FDA DEVICE APPROVAL
FDA DEVICE APPROVAL PROCESS
FDA DRUG APPROVAL
FDA DRUG APPROVAL PROCESS
FDA Established Names and Unique Ingredient Identifier Codes Terminology
FDA Form 1572
FDA investigational device
FDA INVESTIGATIONAL DEVICE EXEMPTION
FDA K10
FDA Modernization Act of 1997
FDA National Drug Code
FDA National Drug Code Directory
FDA NDC
FDA package insert
FDA package insert Abuse section
FDA package insert Adverse reactions section
FDA package insert Animal pharmacology/toxicology section
FDA package insert Boxed warning section
FDA package insert Carcinogenesis & mutagenesis & impairment of fertility section
FDA package insert Clinical pharmacology section
FDA package insert Clinical studies section
FDA package insert Contraindications section
FDA package insert Controlled substance section
FDA package insert Dependence section
FDA package insert Description section
FDA package insert Dosage & administration section
FDA package insert Dosage forms and strengths section
FDA package insert Drug abuse and dependence section
FDA package insert Drug interactions section
FDA package insert Drug/laboratory test interactions section
FDA package insert General precautions section
FDA package insert Geriatric use section
FDA package insert How supplied section
FDA package insert Indications & usage section
FDA package insert Information for patients section
FDA package insert Labor & delivery section
FDA package insert Laboratory tests section
FDA package insert Mechanism of action section
FDA package insert Microbiology section
FDA package insert Nonclinical toxicology section
FDA package insert Nonteratogenic effects section
FDA package insert Nursing mothers section
FDA package insert Overdosage section
FDA package insert Pediatric use section
FDA package insert Pharmacodynamics section
FDA package insert Pharmacokinetics section
FDA package insert Precautions section
FDA package insert Pregnancy section
FDA package insert Recent major changes section
FDA package insert References section
FDA package insert Storage and handling section
FDA package insert Structured patient labelling unclassified section
FDA package insert Structured product laballing patient package insert section
FDA package insert Structured product laballing supplemental patient material
FDA package insert Structured product labelling indexing data elements section
FDA package insert Structured product labelling listing data elements section
FDA package insert Structured product labelling medguide section
FDA package insert Teratogenic effects section
FDA package insert Use in specific populations section
FDA package insert User safety warnings section
FDA package insert Warnings and precautions section
FDA package insert Warnings section
FDA pkg insert Abuse
FDA pkg insert Adverse rx
FDA pkg insert Animal pharmacology/toxic
FDA pkg insert Boxed warning
FDA pkg insert Carcinogen/mutagen/imp of
FDA pkg insert Clin pharmacology
FDA pkg insert Clin studies
FDA pkg insert Contraindications
FDA pkg insert Controlled substance
FDA pkg insert Dependence
FDA pkg insert Description section
FDA pkg insert Dose & admin
FDA pkg insert Dose forms/strengths
FDA pkg insert Drug abuse/dependence
FDA pkg insert Drug interactions
FDA pkg insert Drug/lab test interaction
FDA pkg insert General precautions
FDA pkg insert Geriatric use
FDA pkg insert How supplied
FDA pkg insert Indications/usage
FDA pkg insert Info for patients
FDA pkg insert Lab tests
FDA pkg insert Labor & delivery
FDA pkg insert Mechanism of action
FDA pkg insert Microbiology
FDA pkg insert Nonclinical tox
FDA pkg insert Nonteratogenic effects
FDA pkg insert Nursing mothers
FDA pkg insert Overdosage
FDA pkg insert Pediatric use
FDA pkg insert Pharmacodynamics
FDA pkg insert Pharmacokinetics
FDA pkg insert Precautions
FDA pkg insert Pregnancy
FDA pkg insert Recent major changes
FDA pkg insert References
FDA pkg insert SPL indexing data element
FDA pkg insert SPL listing data elements
FDA pkg insert SPL medguide
FDA pkg insert SPL patient pkg insert
FDA pkg insert SPL suppl patient materia
FDA pkg insert SPL unclassified
FDA pkg insert Storage/handling
FDA pkg insert Teratogenic effects
FDA pkg insert Use in specific pop
FDA pkg insert User safety warnings
FDA pkg insert Warnings
FDA pkg insert Warnings/precautions
FDA prod label Back panel
FDA prod label Bottom panel
FDA prod label Bulk ingredient
FDA prod label Environmental warning
FDA prod label Establishment reg
FDA prod label Flap panel
FDA prod label Food safety warning
FDA prod label Guaranteed anal of feed
FDA prod label Human OTC drug
FDA prod label Human Rx drug
FDA prod label Human Rx drug W highlight
FDA prod label Inactive ingredient
FDA prod label Info for owners/caregiver
FDA prod label Lic Bld intermediate/past
FDA prod label Lic min manipulated cells
FDA prod label Lic vaccine bulk int
FDA prod label Medical device
FDA prod label NDC labeler code request
FDA prod label No change notification
FDA prod label Non-standard allergenic
FDA prod label OTC - Active ingredient
FDA prod label OTC - Ask MD
FDA prod label OTC - Ask MD/pharmacist
FDA prod label OTC - Do not use
FDA prod label OTC - Keep out of reach o
FDA prod label OTC - Pregnancy/breast fe
FDA prod label OTC - Purpose
FDA prod label OTC - Questions
FDA prod label OTC - Stop use
FDA prod label OTC - When using
FDA prod label OTC animal drug
FDA prod label OTC Type A MA animal drug
FDA prod label OTC Type B MF animal drug
FDA prod label OTC Type C MF animal drug
FDA prod label Out of business notificat
FDA prod label Prescription animal drug
FDA prod label Principal display panel
FDA prod label Residue warning
FDA prod label Safe handling warning
FDA prod label Side panel
FDA prod label Side panel-L
FDA prod label Side panel-R
FDA prod label Top panel
FDA prod label Vaccine
FDA prod label Veterinary indications
FDA prod label VFD A MA animal drug
FDA prod label VFD B MF animal drug
FDA prod label VFD C MF animal drug
FDA product label
FDA product label Back panel of package
FDA product label Bottom panel of package
FDA product label Bulk ingredient
FDA product label Environmental warning section
FDA product label Establishment registration
FDA product label Flap panel of package
FDA product label Food safety warning section
FDA product label Guaranteed analysis of feed section
FDA product label Human OTC drug label
FDA product label Human prescription drug label
FDA product label Human prescription drug label with highlights
FDA product label Inactive ingredient section
FDA product label Information for owners or caregivers section
FDA product label Licensed blood intermediate/paste label
FDA product label Licensed minimally manipulated cells label
FDA product label Licensed vaccine bulk intermediate label
FDA product label Medical device
FDA product label NDC labeler code request
FDA product label No change notification
FDA product label Non-standardized allergenic label
FDA product label OTC - Active ingredient section
FDA product label OTC - Ask doctor or pharmacist section
FDA product label OTC - Ask doctor section
FDA product label OTC - Do not use section
FDA product label OTC - Keep out of reach of children section
FDA product label OTC - Pregnancy or breast feeding section
FDA product label OTC - Purpose section
FDA product label OTC - Questions section
FDA product label OTC - Stop use section
FDA product label OTC - When using section
FDA product label OTC animal drug label
FDA product label OTC Type A medicated article animal drug label
FDA product label OTC Type B medicated feed animal drug label
FDA product label OTC Type C medicated feed animal drug label
FDA product label Out of business notification
FDA product label Prescription animal drug label
FDA product label Principal display panel of package
FDA product label Residue warning section
FDA product label Safe handling warning section
FDA product label Side panel of package
FDA product label Side panel of package Left
FDA product label Side panel of package Right
FDA product label Top panel of package
FDA product label Vaccine label
FDA product label Veterinary indications section
FDA product label VFD Type A medicated article animal drug label
FDA product label VFD Type B medicated feed animal drug label
FDA product label VFD Type C medicated feed animal drug label
FDA Regulated Product Submission Reporting
FDA Requested
FDA Requested Report
FDA RPS Adventitious Agents Safety Evaluation [Name, Dosage Form, Manufacturer]
FDA RPS Advertisements And Promotional Labeling Transmittal: FDA Form 2253
FDA RPS Analytical Methods And Validation Reports
FDA RPS Annotated Comparison With Listed Drug
FDA RPS Annotated Draft Labeling Text
FDA RPS Annual Report Transmittal: FDA Form 2252
FDA RPS Appendices: Novel Excipients
FDA RPS Appendices: Regional Information
FDA RPS Application Form: FDA Form 1571
FDA RPS Application Form: FDA Form 356h
FDA RPS Approved Labeling Text For Listed Drug
FDA RPS Basis For Submission Statement
FDA RPS Bioavailability (BA) Study Reports And Related Information
FDA RPS Body Of Data
FDA RPS Body Of Data: Appendices
FDA RPS Body Of Data: Drug Product [Name, Dosage Form, Manufacturer]
FDA RPS Body Of Data: Drug Substance [Name, Manufacturer]
FDA RPS Carcinogenicity: Long Term Studies [Species]
FDA RPS Carcinogenicity: Other Studies
FDA RPS Carcinogenicity: Short Or Medium Term Studies
FDA RPS Change In Contact/Agent
FDA RPS Change In Ownership Of An Application
FDA RPS Change In Sponsor
FDA RPS Change Of Address Or Corporate Name
FDA RPS Characterization: Impurities
FDA RPS Clinical Overview
FDA RPS Clinical Study Reports And Related Information
FDA RPS Clinical Summary
FDA RPS Clinical Summary: References
FDA RPS Comparative BA And Bioequivalence (BE) Study Reports And Related Information
FDA RPS Comparison Of Generic Drug And Reference Listed Drug
FDA RPS Contact/Sponsor/Applicant Information
FDA RPS Control Of Drug Product
FDA RPS Control Of Drug Product: Analytical Procedures
FDA RPS Control Of Drug Product: Batch Analyses
FDA RPS Control Of Drug Product: Characterization Of Impurities
FDA RPS Control Of Drug Product: Justification Of Specification(s)
FDA RPS Control Of Drug Product: Specification(s)
FDA RPS Control Of Drug Product: Validation Of Analytical Procedures
FDA RPS Control Of Drug Substance
FDA RPS Control Of Drug Substance: Analytical Procedures
FDA RPS Control Of Drug Substance: Batch Analyses
FDA RPS Control Of Drug Substance: Justification Of Specification
FDA RPS Control Of Drug Substance: Specification
FDA RPS Control Of Drug Substance: Validation Of Analytical Procedures
FDA RPS Control Of Excipients [Name]
FDA RPS Control Of Excipients: Analytical Procedures
FDA RPS Control Of Excipients: Justification Of Specifications
FDA RPS Control Of Excipients: Novel Excipients
FDA RPS Control Of Excipients: Specification(s)
FDA RPS Control Of Excipients: Validation Of Analytical Procedures
FDA RPS Correspondence Regarding Exception From Informed Consent For Research
FDA RPS Correspondence Regarding Meetings
FDA RPS Correspondence Related To Dispute Resolution
FDA RPS Cross Reference To Other Applications
FDA RPS Debarment Certification
FDA RPS Description And Composition Of The Drug Product
FDA RPS Dispute Resolution
FDA RPS Distribution Data
FDA RPS Draft Carton And Container Labels
FDA RPS Draft Labeling Text
FDA RPS Drug Product: Container Closure System
FDA RPS Drug Product: Controls Of Critical Steps And Intermediates
FDA RPS Drug Product: Description Of Manufacturing Process And Process Controls
FDA RPS Drug Product: Manufacture
FDA RPS Drug Product: Manufacturer(s)
FDA RPS Drug Product: Pharmaceutical Development
FDA RPS Drug Product: Post-Approval Stability Protocol And Stability Commitment
FDA RPS Drug Product: Process Validation And Or Evaluation
FDA RPS Drug Product: Reference Standards Or Materials
FDA RPS Drug Product: Stability
FDA RPS Drug Product: Stability Data
FDA RPS Drug Product: Stability Summary And Conclusion
FDA RPS Drug Substance: Characterization
FDA RPS Drug Substance: Container Closure Systems
FDA RPS Drug Substance: Control Of Materials
FDA RPS Drug Substance: Controls Of Critical Steps And Intermediates
FDA RPS Drug Substance: Description Of Manufacturing Process And Process Controls
FDA RPS Drug Substance: General Information
FDA RPS Drug Substance: General Properties
FDA RPS Drug Substance: Manufacture
FDA RPS Drug Substance: Manufacturer(s)
FDA RPS Drug Substance: Nomenclature
FDA RPS Drug Substance: Post Approval Stability Protocol And Stability Commitment
FDA RPS Drug Substance: Process Validation And/Or Evaluation
FDA RPS Drug Substance: Reference Standards Or Materials
FDA RPS Drug Substance: Stability
FDA RPS Drug Substance: Stability Data
FDA RPS Drug Substance: Stability Summary And Conclusions
FDA RPS Drug Substance: Structure
FDA RPS Efficacy Information Amendment
FDA RPS Elucidation Of Structure And Other Characteristics
FDA RPS Excipients Of Human Or Animal Origin
FDA RPS Exclusivity Request
FDA RPS Exemption From Informed Consent For Research
FDA RPS Extrinsic Factor Study Reports And Related Information
FDA RPS Facilities And Equipment [Name, Manufacturer]
FDA RPS Fast Track Designation Request
FDA RPS Fast Track Designation Withdrawal Request
FDA RPS Field Alert Reports
FDA RPS Field Copy Certification
FDA RPS Final Carton Or Container Labels
FDA RPS Final Labeling
FDA RPS Final Labeling Text
FDA RPS Final Package Insert (Package Inserts, Patient Information, Medication Guides)
FDA RPS Financial Certification And Disclosure
FDA RPS Foreign Labeling
FDA RPS Foreign Marketing History
FDA RPS General Investigational Plan
FDA RPS Generic Drug Enforcement Act Statement
FDA RPS Genotoxicity: In Vitro
FDA RPS Genotoxicity: In Vivo
FDA RPS Healthy Subject PD And PK/PD Study Reports And Related Information
FDA RPS Healthy Subject PK And Initial Tolerability Study Reports And Related Information
FDA RPS In Vitro - In Vivo Correlation Study Reports And Related Information
FDA RPS Inactivation Request
FDA RPS Individual Study Information
FDA RPS Information Amendment: Information Not Covered Under Modules 2 To 5
FDA RPS Intrinsic Factor PK Study Reports And Related Information
FDA RPS Introduction To Summary
FDA RPS Investigational Brochure
FDA RPS Investigational Drug Labeling
FDA RPS Label Comprehension Studies
FDA RPS Labeling History
FDA RPS Labeling Text For Reference Listed Drug
FDA RPS Labeling: Draft Labeling
FDA RPS Labeling: Investigational Drug Labeling
FDA RPS Letter Of Authorization
FDA RPS List Of Authorized Persons To Incorporate By Reference
FDA RPS Listed Drug Labeling
FDA RPS Log Of Outstanding Regulatory Business
FDA RPS Manufacture: Batch Formula
FDA RPS Manufacturing Process Development
FDA RPS Meeting Background Materials
FDA RPS Meeting Request
FDA RPS Module 1 Administrative Information
FDA RPS Module 1: Administrative Information
FDA RPS Module 1: Annual Report
FDA RPS Module 1: Application Status
FDA RPS Module 1: Cover Letters
FDA RPS Module 1: Fast Track
FDA RPS Module 1: Forms
FDA RPS Module 1: Labeling
FDA RPS Module 1: Meetings
FDA RPS Module 1: Other Correspondence
FDA RPS Module 1: References
FDA RPS Module 2 Summaries
FDA RPS Module 3 Quality
FDA RPS Module 3: Literature References
FDA RPS Module 4 Nonclinical Study Reports
FDA RPS Module 4: Literature References
FDA RPS Module 4: Pharmacology
FDA RPS Module 4: Study Reports
FDA RPS Module 5 Clinical Study Reports
FDA RPS Module 5: Literature References
FDA RPS Nonclinical Overview
FDA RPS Nonclinical Written And Tabulated Summaries
FDA RPS Nonclinical Written And Tabulated Summaries: Introduction
FDA RPS Notification Of Charging Under Treatment IND
FDA RPS Notification Of Discontinuation Of Clinical Trial
FDA RPS Other Correspondence Regarding Pediatric Exclusivity Or Study Plans
FDA RPS Other Correspondence: Environmental Analysis
FDA RPS Other Methods Validation Information
FDA RPS Other Pharmacokinetic Studies
FDA RPS Other Toxicity Studies: Antigenicity
FDA RPS Other Toxicity Studies: Dependence
FDA RPS Other Toxicity Studies: Immunotoxicity
FDA RPS Other Toxicity Studies: Impurities
FDA RPS Other Toxicity Studies: Mechanistic Studies
FDA RPS Other Toxicity Studies: Metabolites
FDA RPS Other Toxicity Studies: Other
FDA RPS Patent And Exclusivity
FDA RPS Patent Certification
FDA RPS Patent Information
FDA RPS Patient PD And PK/PD Study Reports And Related Information
FDA RPS Patient PK And Initial Tolerability Study Reports And Related Information
FDA RPS Pediatric Administrative Information
FDA RPS Pharmacokinetic Tabulated Summary
FDA RPS Pharmacokinetic Written Summary
FDA RPS Pharmacokinetics: Absorption
FDA RPS Pharmacokinetics: Distribution
FDA RPS Pharmacokinetics: Drug Interactions
FDA RPS Pharmacokinetics: Excretion
FDA RPS Pharmacokinetics: Metabolism
FDA RPS Pharmacology Tabulated Summary
FDA RPS Pharmacology Written Summary
FDA RPS Pharmacology: Pharmacodynamic Drug Interactions
FDA RPS Pharmacology: Primary Pharmacodynamics
FDA RPS Pharmacology: Safety Pharmacology
FDA RPS Pharmacology: Secondary Pharmacodynamics
FDA RPS Plasma Protein Binding Study Reports And Related Information
FDA RPS Population PK Study Reports And Related Information
FDA RPS Pre IND Correspondence
FDA RPS Promotional Material
FDA RPS Proposal For Written Agreement
FDA RPS Proposed Pediatric Study Request And Amendments
FDA RPS Public Disclosure Statement For Exception From Informed Consent For Research
FDA RPS Quality Information Amendment
FDA RPS Quality Overall Summary
FDA RPS Reactivation Request
FDA RPS Reinstatement Request
FDA RPS Reports Of Analyses Of Data From More Than One Study
FDA RPS Reports Of Bioanalytical And Analytical Methods For Human Studies
FDA RPS Reports Of Biopharmaceutic Studies
FDA RPS Reports Of Efficacy And Safety Studies [Indication]
FDA RPS Reports Of Efficacy And Safety Studies: Other Study Reports And Related Information
FDA RPS Reports Of Hepatic Metabolism And Drug Interaction Studies
FDA RPS Reports Of Human Pharmacodynamic (PD) Studies
FDA RPS Reports Of Human Pharmacokinetic (PK) Studies
FDA RPS Reports Of Postmarketing Experience
FDA RPS Reports Of Studies Pertinent To Pharmacokinetics Using Human Biomaterials
FDA RPS Reports Of Studies Using Other Human Biomaterials
FDA RPS Reproductive And Developmental Toxicity: Embryofetal Development
FDA RPS Reproductive And Developmental Toxicity: Fertility And Early Embryonic Development
FDA RPS Reproductive And Developmental Toxicity: Prenatal And Postnatal Development Including Maternal Function
FDA RPS Request For A Waiver
FDA RPS Request For Comments And Advice
FDA RPS Request For Deferral Of Pediatric Studies
FDA RPS Request For Dispute Resolution
FDA RPS Request For Pediatric Exclusivity Determination
FDA RPS Request For Waiver For In Vivo Studies
FDA RPS Request For Waiver Of In Vivo Bioavailability Studies
FDA RPS Request For Waiver Of Pediatric Studies
FDA RPS Request For Withdrawal Of Application Approval
FDA RPS Request To Charge
FDA RPS Risk Management Plans
FDA RPS Rolling Review Request
FDA RPS Safety Information Amendment
FDA RPS Special Protocol Assessment Request
FDA RPS Special Protocol Assessment Request: Carcinogenicity Study
FDA RPS Special Protocol Assessment Request: Clinical Study
31 32 33 34 35